Longevity Health (NASDAQ:XAGE) Shares Down 4.1% – Here’s Why

Longevity Health Holdings, Inc. (NASDAQ:XAGE – Get Free Report) dropped 4.1% during mid-day trading on Thursday . The stock traded as low as $0.26 and last traded at $0.2810. Approximately 5,139 shares traded hands during mid-day trading, an increase of 83% from the average daily volume of 2,808 shares. The stock had previously closed at $0.2929.

Longevity Health Stock Performance

The stock’s 50 day simple moving average is $0.31 and its 200 day simple moving average is $0.45. The firm has a market cap of $500,742.00, a P/E ratio of -0.06 and a beta of 0.37.

Longevity Health Company Profile

(Get Free Report)

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

See Also

• Five stocks we like better than Longevity Health